These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 38966672)

  • 1. Chemical tools for profiling the intracellular ADP-ribosylated proteome.
    Draganov SD; Gruet MJ; Conole D; Balcells C; Siskos AP; Keun HC; Haskard DO; Tate EW
    RSC Chem Biol; 2024 Jul; 5(7):640-651. PubMed ID: 38966672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An Integrated Chemical Proteomics Approach for Quantitative Profiling of Intracellular ADP-Ribosylation.
    Kalesh K; Lukauskas S; Borg AJ; Snijders AP; Ayyappan V; Leung AKL; Haskard DO; DiMaggio PA
    Sci Rep; 2019 Apr; 9(1):6655. PubMed ID: 31040352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An Advanced Strategy for Comprehensive Profiling of ADP-ribosylation Sites Using Mass Spectrometry-based Proteomics.
    Hendriks IA; Larsen SC; Nielsen ML
    Mol Cell Proteomics; 2019 May; 18(5):1010-1026. PubMed ID: 30798302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Site-specific analysis of the Asp- and Glu-ADP-ribosylated proteome by quantitative mass spectrometry.
    Li P; Zhen Y; Yu Y
    Methods Enzymol; 2019; 626():301-321. PubMed ID: 31606080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterizing ADP-Ribosylation Sites Using Af1521 Enrichment Coupled to ETD-Based Mass Spectrometry.
    Anagho HA; Elsborg JD; Hendriks IA; Buch-Larsen SC; Nielsen ML
    Methods Mol Biol; 2023; 2609():251-270. PubMed ID: 36515840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteome-Wide Identification of In Vivo ADP-Ribose Acceptor Sites by Liquid Chromatography-Tandem Mass Spectrometry.
    Larsen SC; Leutert M; Bilan V; Martello R; Jungmichel S; Young C; Hottiger MO; Nielsen ML
    Methods Mol Biol; 2017; 1608():149-162. PubMed ID: 28695509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Profiling of the ADP-Ribosylome in Living Cells.
    Lehner M; Rieth S; Höllmüller E; Spliesgar D; Mertes B; Stengel F; Marx A
    Angew Chem Int Ed Engl; 2022 Apr; 61(18):e202200977. PubMed ID: 35188710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular Tools for the Study of ADP-Ribosylation: A Unified and Versatile Method to Synthesise Native Mono-ADP-Ribosylated Peptides.
    Voorneveld J; Rack JGM; van Gijlswijk L; Meeuwenoord NJ; Liu Q; Overkleeft HS; van der Marel GA; Ahel I; Filippov DV
    Chemistry; 2021 Jul; 27(41):10621-10627. PubMed ID: 33769608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiomics analysis of the NAD
    Jones A; Kraus WL
    Genes Dev; 2022 May; 36(9-10):601-617. PubMed ID: 35654456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemical proteomics reveals ADP-ribosylation of small GTPases during oxidative stress.
    Westcott NP; Fernandez JP; Molina H; Hang HC
    Nat Chem Biol; 2017 Mar; 13(3):302-308. PubMed ID: 28092360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ADPriboDB: The database of ADP-ribosylated proteins.
    Vivelo CA; Wat R; Agrawal C; Tee HY; Leung AK
    Nucleic Acids Res; 2017 Jan; 45(D1):D204-D209. PubMed ID: 27507885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A desthiobiotin labelled NAD
    Rieth S; Spliesgar D; Orth J; Lehner M; Kasprzyk R; Stengel F; Marx A
    Chembiochem; 2024 Mar; 25(5):e202300797. PubMed ID: 38236015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Cell-Line-Specific Atlas of PARP-Mediated Protein Asp/Glu-ADP-Ribosylation in Breast Cancer.
    Zhen Y; Zhang Y; Yu Y
    Cell Rep; 2017 Nov; 21(8):2326-2337. PubMed ID: 29166620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Processing of ADP-ribosylated integrin alpha 7 in skeletal muscle myotubes.
    Zolkiewska A; Moss J
    J Biol Chem; 1995 Apr; 270(16):9227-33. PubMed ID: 7721841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ion-Pairing with Triethylammonium Acetate Improves Solid-Phase Extraction of ADP-Ribosylated Peptides.
    McPherson RL; Ong SE; Leung AKL
    J Proteome Res; 2020 Feb; 19(2):984-990. PubMed ID: 31859514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ADP-ribosylated proteins as old and new drug targets for anticancer therapy: the example of ARF6.
    Dani N; Barbosa AJ; Del Rio A; Di Girolamo M
    Curr Pharm Des; 2013; 19(4):624-33. PubMed ID: 23016858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of ADP-Ribose Acceptor Sites on In Vitro Modified Proteins by Liquid Chromatography-Tandem Mass Spectrometry.
    Leutert M; Bilan V; Gehrig P; Hottiger MO
    Methods Mol Biol; 2017; 1608():137-148. PubMed ID: 28695508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Study into the ADP-Ribosylome of IFN-γ-Stimulated THP-1 Human Macrophage-like Cells Identifies ARTD8/PARP14 and ARTD9/PARP9 ADP-Ribosylation.
    Higashi H; Maejima T; Lee LH; Yamazaki Y; Hottiger MO; Singh SA; Aikawa M
    J Proteome Res; 2019 Apr; 18(4):1607-1622. PubMed ID: 30848916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gas-Phase Fragmentation of ADP-Ribosylated Peptides: Arginine-Specific Side-Chain Losses and Their Implication in Database Searches.
    Gehrig PM; Nowak K; Panse C; Leutert M; Grossmann J; Schlapbach R; Hottiger MO
    J Am Soc Mass Spectrom; 2021 Jan; 32(1):157-168. PubMed ID: 33140951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PARPs and ADP-ribosylation: Deciphering the complexity with molecular tools.
    Dasovich M; Leung AKL
    Mol Cell; 2023 May; 83(10):1552-1572. PubMed ID: 37119811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.